Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects

Publisher： John Wiley & Sons Inc

E-ISSN： 1742-7843|122|3|341-345

ISSN： 1742-7835

Source： BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol.122, Iss.3, 2018-03, pp. : 341-345

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 6, 2015-06 ,pp. : 650-658

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome

By                          

International Journal of Molecular Medicine, Vol. 30, Iss. 1, 2012-01 ,pp. : 185-192

Spandidos Publications

Access to resources Recommend Favorite

Clopidogrel and Side Effects

By  

Cardiology, Vol. 96, Iss. 1, 2001-11 ,pp. : 51-52

Karger

Access to resources Recommend Favorite

The effects of proton pump inhibition on patient‐reported severity of dyspepsia when receiving dual anti‐platelet therapy with clopidogrel and low‐dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 365-374

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Vitexin on the Pharmacokinetics and mRNA Expression of CYP Isozymes in Rats

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 3, 2015-03 ,pp. : 366-372

John Wiley & Sons Inc

Access to resources Recommend Favorite